𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

✍ Scribed by Erik Skof; Martina Rebersek; Zvezdana Hlebanja; Janja Ocvirk


Book ID
115011534
Publisher
BioMed Central
Year
2009
Tongue
English
Weight
288 KB
Volume
9
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.